Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.

Journal Article (Journal Article)

Full Text

Duke Authors

Cited Authors

  • Fichtenbaum, CJ; Ribaudo, HJ; Leon-Cruz, J; Overton, ET; Zanni, MV; Malvestutto, CD; Aberg, JA; Kileel, EM; Fitch, KV; Van Schalkwyk, M; Kumarasamy, N; Martinez, E; Santos, BR; Joseph, Y; Lo, J; Siminski, S; Melbourne, K; Sponseller, CA; Desvigne-Nickens, P; Bloomfield, GS; Currier, JS; Hoffmann, U; Douglas, PS; Grinspoon, SK

Published Date

  • February 3, 2021

Published In

Volume / Issue

  • 223 / 2

Start / End Page

  • 352 -

PubMed ID

  • 33068427

Pubmed Central ID

  • PMC8112120

Electronic International Standard Serial Number (EISSN)

  • 1537-6613

Digital Object Identifier (DOI)

  • 10.1093/infdis/jiaa594


  • eng

Conference Location

  • United States